ici 170809 has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 1 studies
| Studies (ici 170809) | Trials (ici 170809) | Recent Studies (post-2010) (ici 170809) | Studies (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid) | Trials (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid) | Recent Studies (post-2010) (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid) |
|---|---|---|---|---|---|
| 14 | 1 | 0 | 2,577 | 27 | 327 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batey, AJ; Coker, SJ; Shaw, LA | 1 |
1 other study(ies) available for ici 170809 and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Animals; Blood Pressure; Dioxanes; Electrocardiography; Heart; In Vitro Techniques; Male; Myocardial Contraction; Papillary Muscles; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Quinolines; Rats; Rats, Wistar; Refractory Period, Electrophysiological; Serotonin Antagonists; Thromboxane A2; Vasoconstrictor Agents | 1997 |